The hypophysitis and diabetes mellitus induced by anti-CTLA-4 and anti-PD-1/PD-L1, respectively, can serve as examples of cases in which auto-antibodies, while undetectable at baseline, developed significantly following treatment with ICIs (64, 81). This evidence concerns the gene PDCD1 and diabetes mellitus.